Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

SELL
$6.56 - $10.95 $4.32 Million - $7.21 Million
-658,024 Reduced 8.62%
6,979,844 $47.8 Million
Q2 2023

Aug 14, 2023

BUY
$7.89 - $10.64 $2.09 Million - $2.82 Million
265,267 Added 3.6%
7,637,868 $79.2 Million
Q1 2023

May 12, 2023

BUY
$7.07 - $17.95 $13.4 Million - $33.9 Million
1,888,588 Added 34.44%
7,372,601 $59.6 Million
Q4 2022

Feb 13, 2023

BUY
$14.33 - $18.37 $29.1 Million - $37.3 Million
2,030,160 Added 58.78%
5,484,013 $86.4 Million
Q3 2022

Nov 14, 2022

SELL
$13.07 - $18.22 $18.9 Million - $26.4 Million
-1,447,410 Reduced 29.53%
3,453,853 $54.4 Million
Q2 2022

Aug 15, 2022

SELL
$10.16 - $17.08 $8.42 Million - $14.2 Million
-828,990 Reduced 14.47%
4,901,263 $68.4 Million
Q1 2022

May 16, 2022

BUY
$9.74 - $17.92 $1.86 Million - $3.42 Million
190,985 Added 3.45%
5,730,253 $98.8 Million
Q4 2021

Feb 11, 2022

BUY
$12.27 - $18.49 $1.46 Million - $2.2 Million
118,815 Added 2.19%
5,539,268 $80.5 Million
Q3 2021

Nov 15, 2021

BUY
$13.38 - $18.8 $9.67 Million - $13.6 Million
722,704 Added 15.38%
5,420,453 $97.6 Million
Q2 2021

Aug 16, 2021

BUY
$17.08 - $29.6 $66 Million - $114 Million
3,866,420 Added 465.09%
4,697,749 $82.5 Million
Q1 2021

May 17, 2021

BUY
$5.86 - $27.73 $4.87 Million - $23.1 Million
831,329 New
831,329 $21 Million

Others Institutions Holding ACRS

About Aclaris Therapeutics, Inc.


  • Ticker ACRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 66,671,800
  • Market Cap $255M
  • Description
  • Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...
More about ACRS
Track This Portfolio

Track Wellington Management Group LLP Portfolio

Follow Wellington Management Group LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

News

Stay updated on Wellington Management Group LLP with notifications on news.